Aoxing Pharmaceutical Co., Inc. (AXN) Reports Q2 Loss of $0.01

Aoxing Pharmaceutical Co., Inc. (NYSE: AXN) reported Q2 EPS of ($0.01), versus $0.00 reported last year. Revenue for the quarter came in at $2.12 million, versus $1.94 million reported last year.

For earnings history and earnings-related data on Aoxing Pharmaceutical Co., Inc. (AXN) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
• Raymond James on Malibu Boats (MBUU): 'continued soft retail environment'
• C1 Fund reports portfolio growth and share repurchase activity